Neuralink, the neurotechnology startup led by Elon Musk, is accelerating the commercialization of a brain-computer interface (BCI) that connects the human brain and computers. The plan is to begin mass-producing the product in the new year and push ahead with automating the implantation surgery process.
Reuters reported on the 31st (local time) that Musk said on X (formerly Twitter), "Neuralink will begin mass production of BCI in the new year of 2026."
A BCI is a technology that helps patients whose bodies are paralyzed by accidents or disease control various devices with only their thoughts through an implant placed in the brain.
Neuralink resolved safety concerns raised during consultations with the U.S. Food and Drug Administration (FDA) and began human clinical trials in 2024. In fact, reports that the first implant recipient carried out everyday digital activities—such as internet searches and posting on social media—have led some to say the case demonstrated the technology's early potential. As of September last year, 12 patients with severe paralysis worldwide had undergone BCI implant surgery.
In addition, Neuralink said it will push to build a system to automate the entire implantation procedure starting in 2026. Industry watchers say that if expanded production aligns with automated procedures, the pace of adoption could accelerate.